The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells

[1]  P. Leung,et al.  Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells. , 2012, Cancer letters.

[2]  Zhi-xuan Fu,et al.  Heregulin-β1-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2/ErbB3-MAPK/ERK pathway. , 2012, Biochemical and biophysical research communications.

[3]  X. Wan,et al.  The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. , 2012, Biochemical and biophysical research communications.

[4]  A. Ehinger,et al.  The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer , 2012, Journal of Ovarian Research.

[5]  G. Rodriguez,et al.  Ovarian cancer: etiology, risk factors, and epidemiology. , 2012, Clinical obstetrics and gynecology.

[6]  X. Wan,et al.  Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2 , 2012, Journal of Cancer Research and Clinical Oncology.

[7]  E. Prossnitz,et al.  The G-protein-coupled estrogen receptor GPER in health and disease , 2011, Nature Reviews Endocrinology.

[8]  Hai-xia Wen,et al.  [The expression of a novel estrogen receptor, GPR30, in epithelial ovarian carcinoma and its correlation with MMP-9]. , 2010, Sheng li xue bao : [Acta physiologica Sinica].

[9]  C. Chen,et al.  G protein-coupled receptor 30 in tumor development , 2010, Endocrine.

[10]  N. Joste,et al.  GPR30 predicts poor survival for ovarian cancer. , 2009, Gynecologic oncology.

[11]  Didier Picard,et al.  Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF , 2009, The EMBO journal.

[12]  B. Casslén,et al.  Estradiol Attenuates EGF-Induced Rapid uPAR Mobilization and Cell Migration via the G-protein-Coupled Receptor 30 in Ovarian Cancer Cells , 2009, International Journal of Gynecologic Cancer.

[13]  Jie Chen,et al.  Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9 , 2009, BMC Cell Biology.

[14]  Meenakshi Singh,et al.  GPR30: a novel indicator of poor survival for endometrial carcinoma. , 2007, American journal of obstetrics and gynecology.

[15]  Tudor I. Oprea,et al.  G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. , 2007, Cancer research.

[16]  D. Giri,et al.  Distribution of GPR30, a Seven Membrane–Spanning Estrogen Receptor, in Primary Breast Cancer and its Association with Clinicopathologic Determinants of Tumor Progression , 2006, Clinical Cancer Research.

[17]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[18]  D. Fishman,et al.  Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. , 2005, Cancer letters.

[19]  D. Katsaros,et al.  Involvement of Estrogen Receptor β in Ovarian Carcinogenesis , 2004, Cancer Research.

[20]  D. Katsaros,et al.  Involvement of estrogen receptor beta in ovarian carcinogenesis. , 2004, Cancer research.

[21]  N. Auersperg,et al.  Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches , 2002, International Journal of Gynecologic Cancer.

[22]  I. Fidler,et al.  Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.

[23]  A. Berchuck,et al.  Relationship Between Expression of Coactivators and Corepressors of Hormone Receptors and Resistance of Ovarian Cancers to Growth Regulation by Steroid Hormones , 2001, The Journal of the Society for Gynecologic Investigation: JSGI.

[24]  K. Hatch,et al.  Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report. , 1996, Gynecologic oncology.

[25]  R. Rubin.  The war on cancer. , 1996, U.S. news & world report.

[26]  M. McKay,et al.  Cancer of the ovary. , 1994, The New England journal of medicine.

[27]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.